← Back to Research Radar
Academic Publication Academic Publication

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

72
Citations
January 9, 2025
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
56%
🔥

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

No description provided.

crossref.org › academic paper
0%

Targeting of TAMs: can we be more clever than cancer cells?

АbstractWith increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new antican...

crossref.org › academic paper
0%

Energy metabolism in health and diseases

Abstract Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This re...

crossref.org › academic paper
0%

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

No description provided.

crossref.org › academic paper
0%

Mitochondrial dysfunction: mechanisms and advances in therapy

AbstractMitochondria, with their intricate networks of functions and information processing, are pivotal in both health regulation and disease progression. Particularly, mitochondrial dysfunctions ...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy'?

This literature focuses on:

What other academic literature is closely related to 'Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy'?

Yes, highly correlated activity was mapped. An entry titled 'Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.